Organovo Holdings, Inc.

General ticker "ONVO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $3.9M (TTM average)

Organovo Holdings, Inc. does not follow the US Stock Market performance with the rate: -20.5%.

Estimated limits based on current volatility of 3.8%: low 1.86$, high 2.01$

Factors to consider:

  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-03-31 to 2026-03-31

  • 2024-03-31 to 2025-03-31 estimated range: [6.14$, 16.79$]
  • 2025-03-31 to 2026-03-31 estimated range: [3.82$, 11.29$]

Financial Metrics affecting the ONVO estimates:

  • Negative: Non-GAAP EPS, $ of -24.00 <= 0.04
  • Negative: Operating cash flow per share per price, % of -11.43 <= 1.79
  • Negative: negative Net income
  • Positive: 43.26 < Shareholder equity ratio, % of 56.72 <= 63.75
  • Negative: negative Operating income
  • Positive: Interest expense per share, $ of 0 <= 0

Similar symbols

Short-term ONVO quotes

Long-term ONVO plot with estimates

Financial data

YTD 2022-03-31 2023-03-31 2024-03-31
Operating Revenue $1.50MM $0.37MM $0.11MM
Operating Expenses $12.98MM $18.10MM $15.20MM
Operating Income $-11.48MM $-17.73MM $-15.09MM
Non-Operating Income $0.03MM $0.47MM $0.42MM
R&D Expense $3.32MM $8.88MM $5.50MM
Income(Loss) $-11.45MM $-17.26MM $-14.67MM
Taxes $0.00MM $0.00MM $0.00MM
Profit(Loss)* $-11.45MM $-17.26MM $-14.67MM
Stockholders Equity $30.21MM $15.33MM $3.60MM
Inventory $0.00MM $0.00MM $0.30MM
Assets $33.30MM $20.31MM $6.35MM
Operating Cash Flow $-8.45MM $-12.41MM $-14.65MM
Capital expenditure $0.41MM $0.40MM $0.04MM
Investing Cash Flow $-0.41MM $-0.97MM $0.82MM
Financing Cash Flow $0.20MM $0.00MM $1.44MM
Earnings Per Share** $-1.32 $-1.98 $-1.60

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.